India Glycols Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
India Glycols reported net revenue of INR1,130 crores for Q1 FY27, up 9%, with EBITDA of INR170 crores, up 13%, and PAT up 32%. Growth was led by the Spirits business, a 20.6% revenue increase in chemicals, and a record quarter for Ennature Bio Pharma with revenue up 65% and EBITDA up 188%. Management also discussed the NCLT-approved demerger into three separate entities and the mixed impact of the recent conflict-driven crude and freight volatility on different segments.
India Glycols reported FY26 gross revenues of INR9,827 crores, up 8.7%, with net revenues of INR4,211 crores, up 11.8%, driven largely by growth in Potable Spirits and Bio-Fuels segments. EBITDA rose 24.5% to INR654 crores with margin expanding to 15.5%, while PAT grew 26.8% to INR293 crores. Management also described a plant shutdown for catalyst changeover during the quarter, debt prepayment of approximately INR804 crores, and mixed effects of the ongoing war on raw material costs and export demand.